Title for MeetingAbstracts
Alphabetical listing of titles
Dramatic suppression of HIV-1 plasma RNA using a combination of zidovudine, didanosine, zalcitabine, epivir, and interferon-alpha in subjects with recent HIV-1 infection.
Dramatically declining morbidity and mortality in an ambulatory HIV-infected population.
Dramatically declining morbidity and mortality in an ambulatory HIV-infected population.
Drastic increase of CD4 cell counts by CHAM3 therapy in HIV-infected patients.
Drawing as a manner of expression for Pediatric AIDS patients.
Drawing attention to the fact that India has one of the most complex patterns of HIV infection.
DREAM results from Mozambique: predictors of mortality in a HAART treated adult cohort.
Dreams--a strategy for getting heterosexual men to take responsibility.
Dried blood spot DNA & RNA PCR for infant diagnosis of HIV-1 infection in Thailand.
Dried blood spot for use in sentinel surveillance of HIV-1/2.
Dried blood spot HIV PCR improves the diagnosis of HIV in infants.
Dried blood spot samples for CD4 cell count determinations.
Dried blood spots (DBS) : a valuable tool for HIV surveillance in developing or tropical contries.
Dried blood spots (DBS) for monitoring HIV-1 RNA load in neonates and infants.
Drill them before they grow.
Drive-through delivery: where is the "saving"?.
Drivers & AIDS.
Driving and the HIV associated dementia complex: the risk of motor vehicle accidents.
Dronabinol stimulates appetite and causes weight gain in HIV patients.
Drop in HIV seroprevalence rates among men and women entering MA prisons.
Drop out in AZT treated patients.
Drop-in center for persons living with HIV/AIDS program on AIDS, Chulalongkorn Hospital.
Drop-in centers in Montreal: adaptation to the AIDS epidemic.
Drop-out of HIV-infected persons: an assessment of case holding.
Drop-out rate from psychosocial study correlates with impaired well-being.
Dropping Medicare Beneficiaries From HMO Enrollment: The Potential Impact Of Forced Discontinuity Of Care.
Dropping out of an online sex survey: when and why?
Drotrecogin alfa (activated) in severe sepsis: a systematic review of scientific evidence.
Drotrecogin Alfa (Activated) Mortality Benefit in Patients with Severe Sepsis is Unaffected by Adequacy of Antibiotic Therapy: The PROWESS Experience.
Drotrecogin Alfa (Activated) Reduces Mortality in Patients with Severe Sepsis Irrespective of Bacterial Pathogen Classification.